These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33729773)

  • 21. Discovery of a potent dual inhibitor of wild-type and mutant respiratory syncytial virus fusion proteins through the modulation of atropisomer interconversion properties.
    Yamaguchi-Sasaki T; Kawaguchi T; Okada A; Tokura S; Tanaka-Yamamoto N; Takeuchi T; Ogata Y; Takahashi R; Kurimoto-Tsuruta R; Tamaoki T; Sugaya Y; Abe-Kumasaka T; Arikawa K; Yoshida I; Sugiyama H; Kanuma K; Yoshinaga M
    Bioorg Med Chem; 2020 Dec; 28(24):115818. PubMed ID: 33190073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two novel fusion inhibitors of human respiratory syncytial virus.
    Lundin A; Bergström T; Bendrioua L; Kann N; Adamiak B; Trybala E
    Antiviral Res; 2010 Dec; 88(3):317-24. PubMed ID: 20965215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants.
    Yoshida I; Arikawa K; Honma Y; Inatani S; Yoshinaga M; Sugiyama H
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.
    Li L; Yu CH; Ying HZ; Yu JM
    J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection.
    Jordan R; Shao M; Mackman RL; Perron M; Cihlar T; Lewis SA; Eisenberg EJ; Carey A; Strickley RG; Chien JW; Anderson ML; McEligot HA; Behrens NE; Gershwin LJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4889-900. PubMed ID: 26055364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and Biological Evaluation of Novel (thio)semicarbazone-Based Benzimidazoles as Antiviral Agents against Human Respiratory Viruses.
    Francesconi V; Cichero E; Schenone S; Naesens L; Tonelli M
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32218301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice.
    Shi H; Ren K; Lv B; Zhang W; Zhao Y; Tan RX; Li E
    Sci Rep; 2016 Oct; 6():35851. PubMed ID: 27767097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral Activity of Oral JNJ-53718678 in Healthy Adult Volunteers Challenged With Respiratory Syncytial Virus: A Placebo-Controlled Study.
    Stevens M; Rusch S; DeVincenzo J; Kim YI; Harrison L; Meals EA; Boyers A; Fok-Seang J; Huntjens D; Lounis N; Mari N K; Remmerie B; Roymans D; Koul A; Verloes R
    J Infect Dis; 2018 Jul; 218(5):748-756. PubMed ID: 29684148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and Synthesis of 2-(1-Alkylaminoalkyl)pyrazolo[1,5-a]pyrimidines as New Respiratory Syncytial Virus Fusion Protein Inhibitors.
    Yamaguchi-Sasaki T; Tamura Y; Ogata Y; Kawaguchi T; Kurosaka J; Sugaya Y; Iwakiri K; Busujima T; Takahashi R; Ueda-Yonemoto N; Tanigawa E; Abe-Kumasaka T; Sugiyama H; Kanuma K
    Chem Pharm Bull (Tokyo); 2020; 68(4):345-362. PubMed ID: 32238652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
    Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses.
    Yoon JJ; Toots M; Lee S; Lee ME; Ludeke B; Luczo JM; Ganti K; Cox RM; Sticher ZM; Edpuganti V; Mitchell DG; Lockwood MA; Kolykhalov AA; Greninger AL; Moore ML; Painter GR; Lowen AC; Tompkins SM; Fearns R; Natchus MG; Plemper RK
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium.
    Mirabelli C; Jaspers M; Boon M; Jorissen M; Koukni M; Bardiot D; Chaltin P; Marchand A; Neyts J; Jochmans D
    J Antimicrob Chemother; 2018 Jul; 73(7):1823-1829. PubMed ID: 29596680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening and evaluation of anti-respiratory syncytial virus compounds in cultured cells.
    Lundin A; Bergström T; Trybala E
    Methods Mol Biol; 2013; 1030():345-63. PubMed ID: 23821281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus.
    Andries K; Moeremans M; Gevers T; Willebrords R; Sommen C; Lacrampe J; Janssens F; Wyde PR
    Antiviral Res; 2003 Nov; 60(3):209-19. PubMed ID: 14638397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses.
    Pickens JA; Tripp RA
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29361733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Water extract of Cinnamomum cassia Blume inhibited human respiratory syncytial virus by preventing viral attachment, internalization, and syncytium formation.
    Yeh CF; Chang JS; Wang KC; Shieh DE; Chiang LC
    J Ethnopharmacol; 2013 May; 147(2):321-6. PubMed ID: 23518419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ficus religiosa L. bark extracts inhibit human rhinovirus and respiratory syncytial virus infection in vitro.
    Cagno V; Civra A; Kumar R; Pradhan S; Donalisio M; Sinha BN; Ghosh M; Lembo D
    J Ethnopharmacol; 2015 Dec; 176():252-7. PubMed ID: 26528588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1
    Vendeville S; Tahri A; Hu L; Demin S; Cooymans L; Vos A; Kwanten L; Van den Berg J; Battles MB; McLellan JS; Koul A; Raboisson P; Roymans D; Jonckers THM
    J Med Chem; 2020 Aug; 63(15):8046-8058. PubMed ID: 32407115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State of the Art in Respiratory Syncytial Virus Drug Discovery and Development.
    Cockerill GS; Good JAD; Mathews N
    J Med Chem; 2019 Apr; 62(7):3206-3227. PubMed ID: 30411898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides as novel dual inhibitors of respiratory syncytial virus and influenza virus A.
    Zhang GN; Li Q; Zhao J; Zhang X; Xu Z; Wang Y; Fu Y; Shan Q; Zheng Y; Wang J; Zhu M; Li Z; Cen S; He J; Wang Y
    Eur J Med Chem; 2020 Jan; 186():111861. PubMed ID: 31734025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.